Targeting Previously Undruggable Proteins in Cancer Cells
Our innovative approach addresses “undruggable targets” in oncology by targeting intracellular interactions. We are focused on the discovery and development of peptides that enter cells and disrupt protein-protein interactions, impacting transcriptional regulation of oncogenic and immune-modulatory proteins.
More About Us